Dengyue Medicine Nouvel article créé
4 ré

Recombinant Human Albumin Injection (Oryza Sativa): A Breakthrough for Hypoalbuminemia in Cirrhosis | #chinese pharma exports

Recombinant Human Albumin Injection (Oryza Sativa): A Breakthrough for Hypoalbuminemia in Cirrhosis

Recombinant Human Albumin Injection (Oryza Sativa): A Breakthrough for Hypoalbuminemia in Cirrhosis

OsrHSA: >99.9% pure rice-derived rHSA, zero pathogen risk, identical to human plasma albumin. NMPA-approved for cirrhosis hypoalbuminemia (≤30g/L). Fast volume expansion & superior ascites control. Healthgen original · DengYueMed HK direct global supply.